Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06529835 · ClinicalTrials.gov registry record · NA
A Comparison of NeuroSpan Bridge, NeuraGen Nerve Guide, and Nerve Autograft for Peripheral Nerve Repair
A NA study of Peripheral Nerve Injuries, sponsored by Auxilium Biotechnologies.
- Recruiting
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 6
- Study locations
NCT06529835: Recruiting NA study of Peripheral Nerve Injuries, sponsored by Auxilium Biotechnologies.
NCT06529835 is a NA study of Peripheral Nerve Injuries that is actively recruiting participants, run by Auxilium Biotechnologies. The registered enrollment target is 80 participants, below the 452-participant average among 8 other Peripheral Nerve Injuries trials with a reported enrollment target (82% lower). The trial reports 6 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06529835, a NA study of Peripheral Nerve Injuries, is actively recruiting participants, sponsored by Auxilium Biotechnologies.
- RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 6
- Study locations
Study Summary
This is a multicenter, prospective, randomized, subject and evaluator blinded clinical trial to asses the efficacy of Auxilium's NeuroSpan Bridge.
Primary Outcome
This endpoint will examine the change in Static two-point discrimination (s2PD) measured at 12 months.
Conditions Studied
Interventions
- DEVICE NeuroSpan Bridge
- DEVICE NeuroGen Nerve Guide
- DEVICE Nerve Autograft
Study Locations (6)
California
- UCSF Orthopedic Institute - San Francisco
Maryland
- Medstar Union Memorial Hospital- The Curtis National Hand Center - Baltimore
New York
- NYU Langone Orthopedic Center - New York
Ohio
- OSU Wexner Medical Center - Columbus
Pennsylvania
- University of Pennsylvania- Penn Presbyterian Medical Center - Philadelphia
Texas
- The San Antonio Orthopaedic Group (TSAOG Orthopaedics) - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2025-03-21 |
| Est. Completion | 2028-08 |
| Phase | NA |
What NCT06529835 shows while recruiting
NCT06529835 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 452-participant average among 8 other Peripheral Nerve Injuries trials with a reported enrollment target (82% lower).
The record links to 1 condition, with Peripheral Nerve Injuries appearing as the primary indexed condition, and to 3 interventions - of which NeuroSpan Bridge is the first listed.
NCT06529835 lists 6 locations in 6 states (California, Maryland, New York).
Frequently Asked Questions
What is clinical trial NCT06529835 about?
NCT06529835 is a clinical study titled "A Comparison of NeuroSpan Bridge, NeuraGen Nerve Guide, and Nerve Autograft for Peripheral Nerve Repair". This is a multicenter, prospective, randomized, subject and evaluator blinded clinical trial to asses the efficacy of Auxilium's NeuroSpan Bridge.
What is the current status of trial NCT06529835?
This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2025-03-21. Estimated completion is 2028-08.
What conditions does trial NCT06529835 study?
This clinical trial studies the following conditions: Peripheral Nerve Injuries.
What interventions are being tested in trial NCT06529835?
The interventions under investigation include: NeuroSpan Bridge (DEVICE), NeuroGen Nerve Guide (DEVICE), Nerve Autograft (DEVICE).
Who is sponsoring clinical trial NCT06529835?
This trial is sponsored by Auxilium Biotechnologies, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06529835 being conducted?
This trial has 6 study locations across California, Maryland, New York, Ohio, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Peripheral Nerve Injuries
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06529835's enrollment target sits among peer trials
80 3rd of 8 higher than 6 of 8 other Peripheral Nerve Injuries trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Peripheral Nerve Injuries trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Harnessing Neuroplasticity to Enhance Functional Recovery During Chronic Recovery From Upper Extremity Nerve Repair
RECRUITING · NA
-
Promoting Healing of Injured Nerves With Electrical Stimulation Therapy
RECRUITING · NA
-
Upper Extremity Functional Electrical Stimulation (FES) for Restoration of Upper Extremity Function After Spinal Cord Injury (SCI)
RECRUITING · NA
-
Evaluating the Safety and Efficacy of Polyethylene Glycol (PEG) Mediated Fusion (PEG Fusion)
RECRUITING · Phase 2
-
Tesamorelin to Improve Functional Outcomes After Peripheral Nerve Injury
RECRUITING · Phase 2
-
Registry of Avance® Nerve Graft's Utilization and Recovery Outcomes Post Peripheral Nerve Reconstruction
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI